Allergy, Asthma & Immunology Research 2017;9(3):281-284
doi:10.4168/aair.2017.9.3.281
A Case of Cycloserine-Induced Lichenoid Drug Eruption Supported by the Lymphocyte Transformation Test.
Jakyoung KIM 1 ; Shinyoung PARK ; Chul Min JUNG ; Chee Won OH ; Jae Woo KWON
Affiliations
Keywords
Cycloserine; lichenoid eruptions; lymphocyte activation; drug hypersensitivity; drug eruptions
Country
Republic of Korea
Language
English
MeSH
ACTIONS
ACTIONS
ACTIONS
ACTIONS
ACTIONS
ACTIONS
ACTIONS
ACTIONS
ACTIONS
Abstract
Lichenoid drug eruption (LDE) is a rare form of delayed-type drug eruption. Among anti-tuberculosis (Tb) agents, cycloserine (CS) has been reported as a rare cause of LDE. Positive results on the lymphocyte transformation test (LTT) have not been reported in patients with LDE. In the present case, we performed LTT and a patch test, and successfully proved CS as the offending drug in this patient, who had been treated with multiple anti-Tb drugs. These observations suggest that CS should be considered a possible cause of LDE and that LTT can be an option for the diagnosis of LDE.
备案号: 11010502037788, 京ICP备10218182号-8)